In this study we aimed to evaluate and compare the overall performance of the Khorana,
PROTECHT, and CONKO scores as predictive scores for the occurrence of venous …

Background The Khorana risk score (KRS) for prognosis of venous thromboembolism (VTE)
has been rarely explored in Hispanic populations. Objective To determine the value of the …

Although several scores stratify venous thromboembolism (VTE) risk in solid tumors,
hematologic malignancies (HM) are underrepresented. To develop an internal and external …

Abstract Background The Khorana score is a validated tool to identify cancer patients at
higher risk of venous thromboembolism (VTE). Objective We compared its predictive …

Background Current risk assessment models (RAMs) for prediction of venous
thromboembolism (VTE) risk in the outpatient cancer population have shown poor predictive …

e18005 Background: A predictive model to identify patients on active treatment for solid
tumors at risk for venous thromboembolism (VTE) remains an important clinical need. The …

Even though the Khorana risk score (KRS) has been validated to predict against the
development of VTE among patients with cancer, it has a low positive predictive value. It is …

Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus,
we aimed to develop a nomogram to predict the risk of VTE in these patients. We …

The long-term performance of prediction scores for venous thromboembolism (VTE) in
cancer patients has been poorly investigated. We evaluated the discriminatory performance …

Introduction Cancer associated venous thromboembolism (CAT) is one of the leading cause
of morbidity and mortality in the cancer population. Multiple scoring systems have been …